Gel4med, Inc.
Gel4Med is a pioneering company in the field of regenerative medicine, utilizing bioinspiration and materials engineering to develop advanced biomaterials. Founded out of Harvard Innovation Labs, the company focuses on solving unmet clinical needs with its Smart Materials Platform™ technology, which has received FDA 510(k) market clearance for its lead products G4Derm™ and G4Derm™ Plus. Their mission is to enhance health outcomes and access through innovative medical solutions, with a strong emphasis on collaboration, research, and commercialization.
Industries
Nr. of Employees
small (1-50)
Gel4med, Inc.
1660 Soldiers Field Road, STE 7, #1063 Brighton MA 02135
Products
Biosynthetic biomimetic wound matrix (flowable advanced wound system)
A flowable peptide-based biomimetic matrix designed to manage complex wounds and support surgical reconstruction by mimicking extracellular matrix structure and function.
Biosynthetic biomimetic wound matrix (flowable advanced wound system)
A flowable peptide-based biomimetic matrix designed to manage complex wounds and support surgical reconstruction by mimicking extracellular matrix structure and function.
Services
Research and development collaborations with academic and clinical partners to advance biomaterials for regenerative medicine and specialty surgical applications.
Support for clinical case series and real-world evidence generation in collaboration with medical centers.
Support and coordination for government procurement and distribution through federal contractor partnerships and registered procurement identifiers.
Research and development collaborations with academic and clinical partners to advance biomaterials for regenerative medicine and specialty surgical applications.
Support for clinical case series and real-world evidence generation in collaboration with medical centers.
Support and coordination for government procurement and distribution through federal contractor partnerships and registered procurement identifiers.
Expertise Areas
- Biomaterials design and engineering
- Regenerative medicine and tissue engineering
- Wound care and surgical reconstruction
- Local therapeutic delivery and drug-device combination approaches
Key Technologies
- Self-assembling peptide materials
- Peptide-based biomimetic matrices
- Stimuli-responsive materials
- Tunable biodegradable polymers/matrices
News & Updates
Gel4Med has been awarded highly competitive funding from the NIH SBIR program to support the development of its wound care and surgical reconstruction portfolio.
Partnership with Spartan Medical to supply G4Derm™ Plus and Suprello™ to VA and DoD facilities.
Received a grant to accelerate innovation in tissue engineering and biomaterials development.
Published a case series highlighting rapid healing of diabetic foot ulcers using G4Derm™ Plus.
Recognized as a Top 10 Innovation in Podiatry.
Collaborating with the University of Miami on treatments for spinal cord injury.
Gel4Med has been awarded highly competitive funding from the NIH SBIR program to support the development of its wound care and surgical reconstruction portfolio.
Partnership with Spartan Medical to supply G4Derm™ Plus and Suprello™ to VA and DoD facilities.
Received a grant to accelerate innovation in tissue engineering and biomaterials development.
Published a case series highlighting rapid healing of diabetic foot ulcers using G4Derm™ Plus.
Recognized as a Top 10 Innovation in Podiatry.
Collaborating with the University of Miami on treatments for spinal cord injury.